They aren't just "pandemic stocks." ...

Pfizer (PFE) closed the most recent trading day at $26.97, moving -1.61% from the previous trading session. This change lagged the S&P 500's 1.51% loss on the day. Meanwhile, the Dow lost 0.97%, and ...

Pfizer Inc. Q4 shows post-COVID growth, Seagen-fueled oncology gains, and obesity upside. Click for this updated look at PFE ...

Pfizer has reached a turning point.

This healthcare giant is trading at a discounted price today.

Pfizer (NYSE: PFE) is the name behind one of the world's top-selling products: the coronavirus vaccine. It brought in more than $37 billion at its peak in 2022 and helped the company achieve $100 ...

If you are wondering whether Pfizer's current share price reflects its long term potential or lingering concerns, looking closely at what you are paying for each dollar of its business is a useful ...

Pfizer Inc. (NYSE: PFE) today announced that it has received notice of an unsolicited mini-tender offer by Tutanota LLC ("Tutanota") to purchase up to 1 million shares of Pfizer common stock at a ...

Pfizer (PFE) is a premier American multinational pharmaceutical and biotechnology company. The company has evolved from a ...

Pfizer has reached a transition point following declines of some of its biggest blockbusters. The pharma giant is paving the way to growth through new products and acquisitions. 10 stocks we like ...